• Vensica Therapeutics Partners with Merz americanpharmaceuticalreview
    August 12, 2021
    Vensica Therapeutics, a clinical stage biopharmaceutical company, announced that it has signed a strategic collaboration agreement with Merz Therapeutics, a business of the Merz Group and a leader in the field of neurotoxins.
PharmaSources Customer Service